Predictive progression outcomes and risk stratification in patients with recurrent or metastatic nasopharyngeal carcinoma who received first-line immunochemotherapy.

He, Danjie; Zhang, Yudong; He, Shuiqing; Zhang, Yuzhuo; Dai, Keyao; Xu, Cheng; Huang, Ying

He, Danjie; Zhang, Yudong; He, Shuiqing; Zhang, Yuzhuo; Dai, Keyao; Xu, Cheng; Huang, Ying.

Afiliação

He D; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China
Zhang Y; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510062, People's Republic of China.
He S; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China
Zhang Y; Guangzhou Medical University, Guangzhou, Guangdong, 511436, People's Republic of China.
Dai K; Guangzhou Medical University, Guangzhou, Guangdong, 511436, People's Republic of China.
Xu C; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China
Huang Y; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China

Clin Transl Oncol ; 26(5): 1209-1219, 2024 May.

Article em En | MEDLINE | ID: mdl-38070050

Palavras-chave

Acquired resistance; First-line immunochemotherapy; Nomogram; Progression; Recurrent or metastatic nasopharyngeal carcinoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google